The original premise of the meeting was that, if models of palliative care could be established for HIV/AIDS, these could help us in the UK and the USA to ®nd better ways of serving patients with an uncertain prognosis or from particular areas of social disadvantage. As it turned out, all the presentations and discussions supported this hypothesis.
SIMILARITIES AND DIFFERENCES
There have been links and comparisons between the US and the UK in palliative care since their beginning. Modern palliative and hospice care, as developed by Dame Cicely Saunders and others in the UK, was quickly mirrored by developments in Connecticut, New York and Montreal. Discussions between the two countries fuelled enthusiasm and engendered analysis of the best mechanisms of practice. These new services emphasized research and education, to address the dearth of information on effective treatments and services and to spread best practice more widely. Through these, they demonstrated new ways of providing care directly to patients and their families and those close to them.
Since then services have developed rapidlyÐin different or even opposing directions. Funding mechanisms are many and various. For those attending the meeting, these differences offered opportunities to compare and contrast approaches, and in the workgroups to suggest better ways forward. Many of the future challenges are shared. These include the ageing population af¯icted by chronic disease, increased use of technologies in healthcare, inequalities of access and the rising costs of healthcare.
The terms hospice and palliative care are used in different ways. In the USA, hospice means a programme that is primarily home care. There may be limited use of inpatient beds, with links or shared programmes with nursing homes. Hospice has the advantage of providing all services, including the basic nursing support, when it takes over caring for patients. However, to be eligible for hospice bene®t patients must have a primary caregiver. In the UK, hospice, in the lay mind at least, tends to signify an inpatient unit with beds. Palliative or hospice home care programmes and Macmillan nurses working in multiprofessional teams provide expertise, advice and extra support for patients and their families in the community. These work in partnership with the district nurses and general practitioners, some of whom will have been caring for the patients for much longer. Wider ranges of services have developed, including day-care and palliative-care teams within acute hospitals.
A fundamental concern that dominated many of our debates was the difference in the way the two countries deal with uncertain prognosis. In the USA, the funding mechanisms and organization of care means that hospice bene®t is limited to those patients who are certi®ed to have a prognosis of six months or less. In addition, patients have to choose between hospice care and potentially`active' treatments, and can shift from active care to hospice care virtually overnight. Thus, the total time spent in hospice programmes, including the home care, is usually only a couple of weeksÐvery little time in which to work with patients and families who have complex problems. The general view, including that of the US participants, was that these policies need to be changed.
The UK has taken a different approach to patients with uncertain prognosis. Palliative care is seen as a gradually increasing component of care, from diagnosis to death and on into bereavement. Services rely on referrals from other professionals. In addition, they accept patients for`specialist palliative care' according to the complexity of problems experienced, and whether the disease is progressing. Thè palliative care approach', which includes a basic understanding of symptom management and communication, should be something that all professionals working in healthcare can practise. This has meant that patients spend a long time in UK palliative home care programmesÐan average of about ®fteen weeks. The stays in inpatient hospices remain short, just under four weeks, though about 40% of admissions end in discharge rather than death. However, the lack of clarity in de®nitions leads to wide variations in practice. Concern about being unable to discharge patients with slowly progressive conditions, or those with a trajectory of illness that swings between deterioration and improvement, has made many British hospices reluctant to accept patients who have non-cancer conditions or who are very old. The suggestion is that the palliative care approach is more suitable. Thus, overall, only about 5% of patients entering hospice or palliative care services have a diagnosis other than cancer.
Both countries, therefore, urgently need information on how best to serve patients with an uncertain prognosis or with an unpredictable trajectory of illness, such as those with HIV/AIDS. Research is required to show whether the answers lie in hospice and palliative care or something else. How well do the models of shared care really work in the UK, and can the USA develop effective models that are not constrained by the existing rule of a six-month prognosis? A research study rigorously comparing quality of care in the two countries would aid this, and existing datasets could be a starting-point.
EDUCATION
What about education? In the UK, the recognition of palliative medicine as a specialty in 1987 and the work of the Association for Palliative Medicine, along with demonstrations of good practice (such as that in Southampton), have generated substantial changes in the medical undergraduate curriculum. After guidance from the General Medical Council, most if not all medical schools now include palliative medicine and care of the dying. Doctors specializing in palliative medicine have to undergo a speci®c training programme over four years. In the USA there has been much work in developing fellowships through the Project on Death in America and in continuing medical education through the American Medical Association EPEC programme, and there is a certifying examination for doctors who have practised in hospice. Both countries have initiatives among nursing, social work, clergy and professions allied to medicine.
However, the education is patchy. All professionals, working at all levels in clinical care, require it; and places that do not provide education in palliative care should be identi®ed and encouraged to change. In both countries more effort should be given to multiprofessional education, along with strategies to reach patients who are disadvantaged. A sharing of approaches, materials and methods would help professionals in both countries drive forward their programmes.
ACCESS
Addressing access to care and social disadvantage, US participants found much to admire in the universalcoverage systems of the UK, but were surprised to learn that access is nonetheless unequal. Charitable organizations such as Cancer Black Care are important in reaching out to those who are not accessing services in the UK. In the USA, the US Department of Health and Human Services, Health Resources and Services Administration has funded programmes that speci®cally target people from socially deprived areas and minority groupsÐbut gaps remain.
Poor access is not con®ned to palliative care; it applies to every component of healthcare, from prevention, through treatment, to end-of-life care. Unless access is improved across the whole range of healthcare, patients may miss out on potentially curative or life-prolonging treatments. This is a particular issue in HIV/AIDS care, where the new combination therapies are not made universally available, but it also applies to cancer prevention and treatment and many other conditions. Patients and families from disadvantaged groups will be suspicious of a healthcare system that seeks to improve their access to healthcare only at the end of life. However, if model systems for access could be developed in palliative care, these could become object-lessons for other services.
FUNDING
Funding mechanisms were considered at length. These in¯uence the organization of palliative care, the type of services and treatments provided, and the patients and families catered for. In many circumstances funding is fragmented, and integration of funds into a coordinated single pipe' system, along with investment in this type of care, was proposed. The existing¯ows of ®nancial resources would need analysis, and the single funding system would need to be tested in feasibility studies.
Funding for research and education was also an important issue. Much has been achieved in the USA through the work of major philanthropic organizations. The Robert Wood Johnson Foundation, the Project on Death in America of the Open Society Institute, and the National Institutes of Health have all worked to develop programmes of research, education and exchange, enhancing the evidence base and the science base of end-of-life care and increasing its recognition at national, international and local levels. In the UK, research and education funding has primarily come from the National Health Service Research and Development or educational programmes, with a lesser input from charities. The level of support is much lower than in the USA. No charity has addressed the need for substantial research to underpin the practice of palliative care, although the Nuf®eld Foundation has made an important ®rst step in its Buckinghamshire symposium, by raising the policy issues. But research in palliative care involves consideration of complex issues in a patient and caregiver group who are particularly dif®cult to interview. Methodological development is much needed. care is to move forward, both countries must establish a research base and from it develop appropriate education. Finally, all those who attended found the dialogue important. There was a strong recommendation that a report of the deliberations be published for wider debate. In addition, participants were keen to continue the discussion, including ways to implement the recommendations, through future meetings. 
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